{"schema_version":"secwatch.filing_event.v1","accession":"0000010795-24-000064","form_type":"8-K","ticker":"BDX","cik":"0000010795","company_name":"BECTON DICKINSON & CO","filed_at":"2024-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.111527+00:00","generated_at":"2026-05-31T13:38:15.085381+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"BD Q3 adjusted EPS $3.50 beats, raises FY24 guidance; acquires Edwards Critical Care for $4.2B","bullets":["Revenue $4.99B as reported, $5.057B adjusted; organic revenue growth 5.2% YoY.","GAAP diluted EPS $1.68 (+23.5% YoY); adjusted diluted EPS $3.50 (+18.2% YoY).","Year-to-date free cash flow $2.2B, up over 100% YoY.","FY2024 adjusted EPS guidance raised to $13.05-$13.15; organic revenue growth guidance 5.0%-5.25%.","Announced agreement to acquire Edwards Lifesciences' Critical Care Product Group for $4.2B."],"urls":{"canonical":"https://secwatch.observer/filing/0000010795-24-000064","json":"https://secwatch.observer/filing/0000010795-24-000064.json","markdown":"https://secwatch.observer/filing/0000010795-24-000064.md","text":"https://secwatch.observer/filing/0000010795-24-000064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000064/0000010795-24-000064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/10795/000001079524000064/bdx-20240801.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T13:38:15.085381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}